Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus

References

• KuhnRJZhangWRossmannMGStructure of dengue virus: implications for flavivirus organization, maturation, and fusionCell2002108571772511893341
   PubMed Web of Science ®Google Scholar
• InnisBLThirawuthVHemachudhaCIdentification of continuous epitopes of the envelope glycoprotein of dengue type 2 virusAm J Trop Med Hyg19894066766872472749
   PubMed Web of Science ®Google Scholar
• CalisherCHKarabatsosNDalrympleJMAntigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antiseraJ Gen Virol198970Pt 137432543738
   PubMed Web of Science ®Google Scholar
• MakinoYTadanoMSaitoMStudies on serological cross-reaction in sequential flavivirus infectionsMicrobiol Immunol199438129519557723688
   PubMed Web of Science ®Google Scholar
• ChunsuttiwatSIssues Related to Integration of JE Vaccine into National EPI: Experience from ThailandBangkok, ThailandDepartment of Communicable Disease Control, Ministry of Public Health1998
   Google Scholar
• MartinDABiggerstaffBJAllenBJohnsonAJLanciottiRSRoehrigJTUse of immunoglobulin M cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United StatesClin Diagn Lab Immunol20029354454911986257
   PubMedGoogle Scholar
• OlsenSJSupawatKCampbellAPJapanese encephalitis virus remains an important cause of encephalitis in ThailandInt J Infect Dis20101410e888e89220674433
   PubMed Web of Science ®Google Scholar
• MansfieldKLHortonDLJohnsonNFlavivirus-induced antibody cross-reactivityJ Gen Virol201192Pt 122821282921900425
   PubMed Web of Science ®Google Scholar
• GrossmanRAGouldDJSmithTJJohnsenDOPantuwatanaSStudy of Japanese encephalitis virus in Chiangmai Valley, Thailand. I. Introduction and study designAm J Epidemiol19739821111204353435
   PubMed Web of Science ®Google Scholar
• van der SchaarHMWilschutJCSmitJMRole of antibodies in controlling dengue virus infectionImmunobiology2009214761362919261353
   PubMed Web of Science ®Google Scholar
• HalsteadSBO’RourkeEJDengue viruses and mononuclear hagocytes. I. Infection enhancement by non-neutralizing antibodyJ Exp Med19771461201217406347
   PubMed Web of Science ®Google Scholar
• SangkawibhaNRojanasuphotSAhandrikSRisk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreakAm J Epidemiol198012056536696496446
   PubMed Web of Science ®Google Scholar
• ReiterPYellow fever and dengue: a threat to Europe?Euro Surveill201015101950920403310
   PubMedGoogle Scholar
• GarcíaGSierraBPérezABAsymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcgammaRIIa polymorphismAm J Trop Med Hyg20108261153115620519616
   PubMed Web of Science ®Google Scholar
• HarrisEVideaEPérezLClinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in NicaraguaAm J Trop Med Hyg2000631–251111357995
   PubMed Web of Science ®Google Scholar
• SabinABResearch on dengue during World War IIAm J Trop Med Hyg195211305014903434
   PubMedGoogle Scholar
• HalsteadSBChowJMarchetteNJImmunological enhancement of dengue virus replicationNat New Biol1973243122242617319077
   PubMedGoogle Scholar
• HokeCHNisalakASangawhipaNProtection against Japanese encephalitis by inactivated vaccinesN Engl J Med1988319106086142842677
   PubMed Web of Science ®Google Scholar
• GibbonsRVKalanaroojSJarmanRGAnalysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequencesAm J Trop Med Hyg200777591091317984352
   PubMed Web of Science ®Google Scholar
• AndersonKBGibbonsRVThomasSJPre-existing Japanese encephalitis virus neutralizing antibodies and increased symptomatic dengue illness in a school-based cohort in ThailandPLoS Negl Trop Dis2011510e131121991398
   PubMed Web of Science ®Google Scholar
• WahalaWMKrausAAHaymoreLBAccavitti-LoperMAde SilvaAMDengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibodyVirology2009392110311319631955
   PubMed Web of Science ®Google Scholar
• BeltramelloMWilliamsKLSimmonsCPThe human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activityCell Host Microbe20108327128320833378
   PubMed Web of Science ®Google Scholar
• SchieffelinJSCostinJMNicholsonCONeutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patientVirol J201072820132551
   PubMed Web of Science ®Google Scholar
• DejnirattisaiWJumnainsongAOnsirisakulNCross-reacting antibodies enhance dengue virus infection in humansScience2010328597974574820448183
   PubMed Web of Science ®Google Scholar
• de AlwisRBeltramelloMMesserWBIn-depth analysis of the antibody response of individuals exposed to primary dengue virus infectionPLoS Negl Trop Dis201156e118821713020
   PubMed Web of Science ®Google Scholar
• SetthapramoteCSasakiTPuipromOHuman monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infectionBiochem Biophys Res Commun2012423486787222713454
   PubMed Web of Science ®Google Scholar
• SasakiTSetthapramoteCKurosuTDengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infectionAntiviral Res201398342343123545366
   PubMed Web of Science ®Google Scholar
• KurosuTKhamlertCPhanthanawiboonSIkutaKAnantapreechaSHighly efficient rescue of dengue virus using a co-culture system with mosquito/mammalian cellsBiochem Biophys Res Commun2010394239840420214880
   PubMed Web of Science ®Google Scholar
• OkunoYIgarashiAFukaiKNeutralization tests for dengue and Japanese encephalitis viruses by the focus reduction method using peroxidase-anti-peroxidase stainingBiken J1978214137147383069
   PubMedGoogle Scholar
• FalconarAKIdentification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteinsArch Virol1999144122313233010664386
   PubMed Web of Science ®Google Scholar
• Kimura-KurodaJYasuiKAntigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodiesJ Gen Virol198667Pt 12266326722432163
   PubMed Web of Science ®Google Scholar
• HeinzFXStiasnyKFlaviviruses and their antigenic structureJ Clin Virol20125428929522999801
   PubMed Web of Science ®Google Scholar
• CrillWDChangGJLocalization and characterization of flavivirus envelope glycoprotein cross-reactive epitopesJ Virol20047824139751398615564505
   PubMed Web of Science ®Google Scholar
• MullerDAYoungPRThe flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarkerAntiviral Res201398219220823523765
   PubMed Web of Science ®Google Scholar
• CardosaMJWangSMSumMSHTioPHAntibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis virusesBMC Microbiol20022912019028
   PubMed Web of Science ®Google Scholar
• LaiCYTsaiWYLinSRAntibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain IIJ Virol200882136631664318448542
   PubMed Web of Science ®Google Scholar
• PincusSMasonPWKonishiERecombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitisVirology199218712902971736531
   PubMed Web of Science ®Google Scholar
• ColombageGHallRPavyMLobigsMDNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virusVirology199825011511639770429
   PubMed Web of Science ®Google Scholar
• ShuPYChenLKChangSFDengue NS1-specific antibody responses: isotype distribution and serotyping in patients with dengue fever and dengue hemorrhagic feverJ Med Virol200062222423211002252
   PubMed Web of Science ®Google Scholar
• ChungKMThompsonBSFremontDHDiamondMSAntibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile virus-infected cellsJ Virol200781179551955517582005
   PubMed Web of Science ®Google Scholar
• LitzbaNKladeCSLedererSNiedrigMEvaluation of serological diagnostic test systems assessing the immune response to Japanese encephalitis vaccinationPLoS Negl Trop Dis2010411e88321103412
   PubMed Web of Science ®Google Scholar
• ShuPYChenLKChangSFAntibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of mAb-based indirect ELISA to differentiate infection from vaccinationVaccine20011913–141753176311166901
   PubMed Web of Science ®Google Scholar